The latest closing stock price for Prelude Therapeutics as of September 18, 2024 is 2.44.
An investor who bought $1,000 worth of Prelude Therapeutics stock at the IPO in 2020 would have $-907 today, roughly -1 times their original investment - a -44.76% compound annual growth rate over 4 years.
The all-time high Prelude Therapeutics stock closing price was 91.68 on February 10, 2021.
The Prelude Therapeutics 52-week high stock price is 6.80, which is 178.7% above the current share price.
The Prelude Therapeutics 52-week low stock price is 1.66, which is 32% below the current share price.
The average Prelude Therapeutics stock price for the last 52 weeks is 3.94.
An investor who bought $1,000 worth of Prelude Therapeutics stock at the IPO in 2020 would have $-907 today, roughly -1 times their original investment - a -44.76% compound annual growth rate over 4 years.
The all-time high Prelude Therapeutics stock closing price was 91.68 on February 10, 2021.
The Prelude Therapeutics 52-week high stock price is 6.80, which is 178.7% above the current share price.
The Prelude Therapeutics 52-week low stock price is 1.66, which is 32% below the current share price.
The average Prelude Therapeutics stock price for the last 52 weeks is 3.94.